LUNG CANCER
Clinical trials for LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER trials appear
Sign up with your email to follow new studies for LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lung cancer brain metastasis study halted after just 3 patients
Disease control TerminatedThis study aimed to see if adding the drug pembrolizumab to chemotherapy could help control lung cancer that has spread to the brain without causing new symptoms. It was designed for people with untreated, asymptomatic brain metastases and no specific genetic mutations. However, …
Matched conditions: LUNG CANCER
Phase: PHASE2 • Sponsor: John L. Villano, MD, PhD • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Personalized cell therapy for advanced lung cancer shows early promise
Disease control TerminatedThis study tested a treatment called GT201, which uses immune cells taken from a patient's own tumor to attack cancer. It was designed for adults with advanced lung cancer who had already tried other treatments. The study was stopped early after enrolling only 2 people, so result…
Matched conditions: LUNG CANCER
Phase: NA • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Lung cancer combo study halted early after only 4 patients
Disease control TerminatedThis study tested a combination of the targeted drug osimertinib and chemotherapy as a first treatment for people with advanced non-small cell lung cancer that has uncommon EGFR mutations. The goal was to see if the combo could shrink tumors and delay cancer growth. However, the …
Matched conditions: LUNG CANCER
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
MRI-Guided radiation for lung tumors: a closer look
Disease control TerminatedThis study looked at whether using MRI to guide radiation therapy can help control central lung tumors (tumors near the center of the chest). The approach was compared to standard CT-guided radiation. Only 3 people took part before the study was stopped early. The main goals were…
Matched conditions: LUNG CANCER
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
New cancer drug shows promise in early trial for advanced tumors
Disease control TerminatedThis early-phase study tested a new drug called PHN-010 in 26 people with advanced solid tumors (lung, colon, endometrial, ovarian, or cervical cancer) that had already been treated with at least one prior therapy. The drug is an antibody-drug conjugate designed to deliver a toxi…
Matched conditions: LUNG CANCER
Phase: PHASE1 • Sponsor: Pheon Therapeutics • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
Exercise study for advanced lung cancer ends early
Symptom relief TerminatedThis study looked at whether a mix of exercises could reduce fatigue and improve fitness and quality of life in people with advanced lung cancer. It was designed for patients on long-term immunotherapy. However, the study was stopped early and only enrolled 2 people, so no clear …
Matched conditions: LUNG CANCER
Phase: NA • Sponsor: Indiana University • Aim: Symptom relief
Last updated May 17, 2026 02:14 UTC
-
Scientists hunt for DNA markers to forecast lung cancer's next move
Knowledge-focused TerminatedThis study aimed to find genetic changes that could predict how a type of lung cancer (squamous cell carcinoma) progresses. Researchers planned to collect tissue and blood samples from 200 people with this cancer. The study was stopped early and only 22 people took part, so the r…
Matched conditions: LUNG CANCER
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 17, 2026 02:05 UTC